Archives
-
From mRNA Uptake to Function: A Translational Roadmap
2026-08-16
Translational mRNA research increasingly depends on separating delivery, intracellular trafficking, and protein expression rather than treating transfection as a single endpoint. This article connects findings from heterogeneous blood-cell electroporation with the dual-readout strategy of EZ Cap™ Cy5 EGFP mRNA (5-moUTP), outlining a practical framework for delivery optimization, mechanistic interpretation, and translational decision-making.
-
Cyclophosphamide: From DNA Damage to Translation
2026-08-15
A translational framework for using Cyclophosphamide as both an alkylating chemotherapeutic agent and an immune-modulating research tool. The article connects hepatic bioactivation, DNA cross-linking, apoptosis induction in cancer cells, immune depletion, experimental design, and strategic comparison with topotecan.
-
Trichostatin A (TSA) Workflows for Epigenetic Research
2026-08-14
Trichostatin A (TSA) provides reversible HDAC inhibition for connecting histone acetylation with proliferation, differentiation, and senescence phenotypes. This workflow-centered guide combines cancer assays with a carefully bounded strategy for testing whether chromatin regulation intersects with the mitochondrion-processed TERC-53 pathway.
-
HDAC Inhibitors Repress NUT Function in NUT Carcinoma
2026-08-14
Shiota and colleagues developed a dCAS9-based chemical screen that identified structurally diverse HDAC inhibitors as suppressors of NUT-dependent transcription. The study links HDAC inhibition to disruption of BRD4-NUT megadomains, oncogene repression, differentiation, and enhanced tumor control when combined with bromodomain inhibition.
-
Heparin Sodium as an HSPG Assay Probe
2026-08-13
Heparin sodium is more than a coagulation reagent: it can help researchers interrogate glycan-dependent molecular interactions. This article connects anticoagulation readouts with heparan sulfate proteoglycan biology and offers a controlled framework for interpreting extracellular vesicle uptake assays.
-
ETS1, Mitophagy, and BPD: SENP2/HSPA8/FUNDC1
2026-08-13
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by suppressing excessive mitochondrial damage-induced mitophagy. Its mechanistic contribution is the definition of an ETS1–SENP2–HSPA8–FUNDC1 pathway in which FUNDC1 deSUMOylation promotes chaperone-dependent degradation, linking transcriptional control with mitochondrial quality control.
-
AG-120 (Ivosidenib) in IDH1-Mutant AML
2026-08-12
AG-120 (Ivosidenib) enables a practical workflow for lowering 2-hydroxyglutarate, testing mutant-IDH1 dependency, and linking metabolic inhibition to myeloid differentiation. This guide combines assay design, CD44-informed combination logic, and troubleshooting strategies for reproducible AML research.
-
From PS Biology to Better Capture Workflows
2026-08-12
A translational framework for connecting annexin-V detection of early phosphatidylserine exposure with selective, biotin-enabled magnetic capture—without confusing ex vivo enrichment with in situ measurement.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-08-11
The reference study challenges the prevailing view that AMPK universally promotes autophagy during glucose deprivation. It shows that AMPK suppresses ULK1-dependent autophagy during acute energy stress while preserving the autophagy machinery for recovery, providing a more precise framework for interpreting AMPK activator experiments.
-
Repurposing Loperamide Against Intracellular Bacteria
2026-08-11
The reference study used a cell-based screen of FDA-approved drugs to identify loperamide as an inhibitor of intracellular Salmonella Typhimurium replication. Its central contribution is a host-directed mechanism linking loperamide-induced GPNMB expression with enhanced autophagy, lysosomal activity, and protection in infection models.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-08-10
The 2024 Nature Communications study identifies acetylation-dependent control of the spliceosome protein SmD2 as a mechanism connecting alternative splicing, DNA-damage repair, and PARP-inhibitor response in hepatocellular carcinoma. Its data support combined HDAC2-directed modulation and olaparib as a preclinical strategy, while also positioning SmD2 and BRCA1/FANC cassette-exon regulation as mechanistic biomarkers for further investigation.
-
Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Shifts
2026-08-09
Shukla and colleagues developed a barcoded pseudotyped-virus assay that simultaneously measures how multiple ACE2 sequences support entry by SARS-CoV-2 spike variants. The study shows that variant spikes retain broadly similar compatibility with human ACE2 but can differ substantially in their compatibility with animal ACE2 orthologs, offering a scalable framework for studying host-range evolution.
-
Benzyl-activated Streptavidin Magnetic Beads Guide
2026-08-08
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) combine high-affinity biotin capture with rapid magnetic handling for protein, nucleic-acid, interaction, and screening workflows. This practical guide connects the beads to annexin-V research while emphasizing assay design, quantitative loading, controls, and troubleshooting.
-
AZD3463: A Translational ALK/IGF1R Strategy
2026-08-07
A thought-leadership framework for using AZD3463 to connect ALK and IGF1R biology with pathway-aware assay design, combination studies, and translational decision-making in neuroblastoma and ALK-driven cancer research.
-
KR-12 Peptide–Cu(II) Interactions: Structural Insights and B
2026-08-07
This study applies advanced theoretical and experimental methods to elucidate how the KR-12 fragment of human cathelicidin LL-37 interacts with copper(II) ions. The findings clarify the structural basis for KR-12's antimicrobial and immunomodulatory functions and inform the rational design of peptide-based therapeutics.